NM_001308093.3:c.1276G>A
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001308093.3(GATA4):c.1276G>A(p.Asp426Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000962 in 1,614,200 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001308093.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000631 AC: 96AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00196 AC: 494AN: 251488Hom.: 2 AF XY: 0.00240 AC XY: 326AN XY: 135918
GnomAD4 exome AF: 0.000997 AC: 1457AN: 1461874Hom.: 16 Cov.: 31 AF XY: 0.00138 AC XY: 1001AN XY: 727238
GnomAD4 genome AF: 0.000630 AC: 96AN: 152326Hom.: 0 Cov.: 32 AF XY: 0.000859 AC XY: 64AN XY: 74484
ClinVar
Submissions by phenotype
Tetralogy of Fallot Pathogenic:1Benign:1
- -
The heterozygous p.Asp425Asn variant in GATA4 in 2 individuals with congenital heart defects, including an individual with an unaffected parent and the variant (PMID: 18055909), and has been identified in >1% of South Asian chromosomes and 1 homozygote by ExAC (http://gnomad.broadinstitute.org/). In summary, this variant meets criteria to be classified as benign for autosomal dominant congenital heart defects. -
Atrioventricular septal defect 4 Benign:2
- -
- -
not provided Benign:2
- -
- -
Atrial septal defect 2 Pathogenic:1
- -
Tricuspid regurgitation;C0242855:Pulmonary valve atresia;C1956257:Pulmonic stenosis Uncertain:1
- -
Inborn genetic diseases Uncertain:1
​Based on the available evidence, the deleterious nature of this alteration is uncertain. -
not specified Benign:1
- -
Congenital heart disease Benign:1
Based on the classification scheme VCGS_Germline_v1.3.2, this variant is classified as likely benign. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with congenital heart disease. (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from aspartic acid to asparagine (exon 7). (I) 0251 - This variant is heterozygous. (I) 0308 - Population frequency for this variant is out of keeping with known incidence of congenital heart disease (gnomAD v2: 491 heterozygotes, 2 homozygotes). (SB) 0309 - An alternative amino acid change at the same position to tyrosine has been observed in gnomAD (v3) (1 heterozygote, 0 homozygote). (I) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0808 - Previous reports of pathogenicity for this variant are conflicting. This variant has been classified mostly as benign or VUS in ClinVar. The pathogenic report in ClinVar is based on a publication in 2007 (PMID:18055909). (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
GATA4-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at